1. © Osteoporosis Among Male Saudi Arabs: A Pilot Study Sadat-Ali, M; AlElq, A K FAISAL SPEC HOSP RES CENTRE, ANNALS OF SAUDI MEDICINE; pp: ; Vol: 26 King Fahd University of Petroleum & Minerals Summary BACKGROUND: Little attention has been paid to the problem of male osteopororsis in Saudi Arabia. In this prospective study we assessed the prevalence of male osteoporosis among Saudi Arabs. SUBJECTS AND METHODS: We studied Saudi Arabian males > 50 years of age attending outpatient clinics at King Fahd Hospital of the University, Al-Khobar, between 1 May 2005 and 30 January We determined body mass index (BMI) and tests were done to rule out secondary osteoporosis. All subjects had a bone mineral density (BMD) measurement of the hip area and the lumbar spine using dual energy X-ray absorptiometry (DEXA). A T- score of <=-2.5 SD that of young, healthy adults was taken as osteoporotic and scores between -1 to -2.5 SO were taken as osteopenic. RESULTS: One hundred fifteen patients (mean age, / years; range, 50 to 76 years) had a mean BMI of / (range, 18.5 to 31). Based on hip scans, the prevalence of osteoporosis was 24.3%. Sixty-four percent were osteopenic. Based on scans of the lumbar spine, the prevalence of osteoporosis was 37.4% and 33.9% were osteopenic. Spinal osteoporosis was more common than hip osteoporosis. CONCLUSIONS: Our study indicates that the prevalence of osteoporosis among Saudi Arabian males is higher than among Western males. More studies are needed to determine the national prevalence of male osteoporosis. It is recommended that serious measures to be undertaken to prevent male osteoporosis to stop any future epidemic of catastrophic osteoporosis-related fractures. References: *NAT OST FDN, 2002, AM BON HLTH STAT OST Copyright: King Fahd University of Petroleum & Minerals;

© BILEZIKIAN JP, 1999, J CLIN ENDOCR METAB, V84, P3431 ELDESOUKI M, 1995, SAUDI MED J, V16, P30 ELDESOUKI MI, 2003, SAUDI MED J, V24, P953 GULLBERG B, 1997, OSTEOPOROSIS INT, V7, P407 JACOBSEN SJ, 1992, AM J PUBLIC HEALTH, V82, P1147 KANIS J, 1999, OSTEOPOROSIS INT, V9, P45 KAUFMAN JM, 2000, ANN RHEUM DIS, V59, P765 LOOKER AC, 1997, J BONE MINER RES, V12, P1769 MELTON LJ, 1988, J CLIN EPIDEMIOL, V41, P985 ODEN A, 1998, OSTEOPOROSIS INT, V8, P599 ORWOLL ES, 1998, ENDOCRIN METAB CLIN, V27, P349 POOR G, 1995, J BONE MINER RES, V10, P1900 RAEF H, 2004, ANN SAUDI MED, V24, P242 REGINSTER JY, 1999, PHARMACOECONOMICS, V15, P507 SADATALI M, 1992, P 1 WORLD GCC ORTH C SADATALI M, 1996, ANN SAUDI MED, V16, P414 SADATALI M, 2004, SAUDI MED J, V25, P1623 SADATALI M, 2005, SAUDI MED J, V26, P1588 SEEMAN E, 1999, OSTEOPOROS INT S2, V9, S97 ULLOMMINNICH P, 1999, AM FAM PHYSICIAN, V60, P194 For pre-prints please write to: Copyright: King Fahd University of Petroleum & Minerals;